SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis
Europe - BIT:SVS - IT0005469264 - Common Stock
9.9 EUR
+0.7 (+7.61%)
Overall SVS gets a fundamental rating of 5 out of 10. We evaluated SVS against 62 industry peers in the Health Care Equipment & Supplies industry. SVS has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on SVS.
1. Profitability
1.1 Basic Checks
SVS had positive earnings in the past year.
SVS had a negative operating cash flow in the past year.
In the past 5 years SVS has always been profitable.
Each year in the past 5 years SVS had a positive operating cash flow.
1.2 Ratios
SVS has a Return On Assets of 3.75%. This is comparable to the rest of the industry: SVS outperforms 53.23% of its industry peers.
SVS has a Return On Equity of 10.43%. This is in the better half of the industry: SVS outperforms 66.13% of its industry peers.
SVS has a better Return On Invested Capital (8.04%) than 74.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SVS is below the industry average of 8.76%.
The 3 year average ROIC (6.63%) for SVS is below the current ROIC(8.04%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 10.43% | ||
| ROIC | 8.04% |
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
1.3 Margins
SVS's Profit Margin of 5.09% is in line compared to the rest of the industry. SVS outperforms 50.00% of its industry peers.
In the last couple of years the Profit Margin of SVS has grown nicely.
Looking at the Operating Margin, with a value of 8.71%, SVS is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of SVS has grown nicely.
SVS's Gross Margin of 26.17% is on the low side compared to the rest of the industry. SVS is outperformed by 85.48% of its industry peers.
In the last couple of years the Gross Margin of SVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 5.09% | ||
| GM | 26.17% |
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SVS is creating some value.
SVS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SVS has less shares outstanding
The debt/assets ratio for SVS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.83 indicates that SVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.83, SVS is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
SVS has a Debt/Equity ratio of 0.62. This is a neutral value indicating SVS is somewhat dependend on debt financing.
The Debt to Equity ratio of SVS (0.62) is worse than 70.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.83 |
ROIC/WACC1.12
WACC7.18%
2.3 Liquidity
SVS has a Current Ratio of 1.82. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
SVS has a Current ratio (1.82) which is in line with its industry peers.
SVS has a Quick Ratio of 1.34. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
SVS has a Quick ratio of 1.34. This is in the better half of the industry: SVS outperforms 61.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
Measured over the past years, SVS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.97% on average per year.
Looking at the last year, SVS shows a quite strong growth in Revenue. The Revenue has grown by 9.07% in the last year.
Measured over the past years, SVS shows a quite strong growth in Revenue. The Revenue has been growing by 10.34% on average per year.
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
3.2 Future
Based on estimates for the next years, SVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.83% on average per year.
SVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.93% yearly.
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue Next Year15.76%
Revenue Next 2Y10%
Revenue Next 3Y7.93%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 7.80, the valuation of SVS can be described as very cheap.
Based on the Price/Earnings ratio, SVS is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.19. SVS is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 6.71 indicates a rather cheap valuation of SVS.
Based on the Price/Forward Earnings ratio, SVS is valued cheaply inside the industry as 96.77% of the companies are valued more expensively.
SVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.50.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.8 | ||
| Fwd PE | 6.71 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SVS indicates a rather cheap valuation: SVS is cheaper than 93.55% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.93 |
4.3 Compensation for Growth
SVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SVS's earnings are expected to grow with 14.83% in the coming years.
PEG (NY)0.23
PEG (5Y)0.39
EPS Next 2Y17.92%
EPS Next 3Y14.83%
5. Dividend
5.1 Amount
SVS has a Yearly Dividend Yield of 2.85%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.23, SVS pays a better dividend. On top of this SVS pays more dividend than 88.71% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, SVS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.85% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
19.64% of the earnings are spent on dividend by SVS. This is a low number and sustainable payout ratio.
DP19.64%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
BIT:SVS (10/30/2025, 7:00:00 PM)
9.9
+0.7 (+7.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners6.55%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap55.44M
Revenue(TTM)132.55M
Net Income(TTM)6.74M
Analysts80
Price Target13.87 (40.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.85% |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP19.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)7.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.8 | ||
| Fwd PE | 6.71 | ||
| P/S | 0.42 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.86 | ||
| P/tB | 1.18 | ||
| EV/EBITDA | 4.93 |
EPS(TTM)1.27
EY12.83%
EPS(NY)1.47
Fwd EY14.89%
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS23.67
BVpS11.54
TBVpS8.36
PEG (NY)0.23
PEG (5Y)0.39
Graham Number18.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 10.43% | ||
| ROCE | 10.81% | ||
| ROIC | 8.04% | ||
| ROICexc | 10.91% | ||
| ROICexgc | 14.1% | ||
| OM | 8.71% | ||
| PM (TTM) | 5.09% | ||
| GM | 26.17% | ||
| FCFM | N/A |
ROA(3y)3.03%
ROA(5y)2.75%
ROE(3y)8.2%
ROE(5y)7.97%
ROIC(3y)6.63%
ROIC(5y)6.34%
ROICexc(3y)10.45%
ROICexc(5y)9.43%
ROICexgc(3y)12.81%
ROICexgc(5y)11.57%
ROCE(3y)8.91%
ROCE(5y)8.53%
ROICexgc growth 3Y10.44%
ROICexgc growth 5Y8.61%
ROICexc growth 3Y11.05%
ROICexc growth 5Y7.72%
OM growth 3Y3.27%
OM growth 5Y3.94%
PM growth 3Y7.81%
PM growth 5Y7.66%
GM growth 3Y-3.21%
GM growth 5Y-2.88%
F-Score5
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.36 | ||
| Cap/Depr | 113.41% | ||
| Cap/Sales | 4.68% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | 1.83 |
F-Score5
WACC7.18%
ROIC/WACC1.12
Cap/Depr(3y)111.56%
Cap/Depr(5y)102.51%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3Y23.97%
EPS 5Y19.97%
EPS Q2Q%34.09%
EPS Next Y33.33%
EPS Next 2Y17.92%
EPS Next 3Y14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)9.07%
Revenue growth 3Y14.06%
Revenue growth 5Y10.34%
Sales Q2Q%21.03%
Revenue Next Year15.76%
Revenue Next 2Y10%
Revenue Next 3Y7.93%
Revenue Next 5YN/A
EBIT growth 1Y17.64%
EBIT growth 3Y17.79%
EBIT growth 5Y14.69%
EBIT Next Year89.52%
EBIT Next 3Y28.15%
EBIT Next 5YN/A
FCF growth 1Y-245.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.92%
OCF growth 3Y26.58%
OCF growth 5Y-3.68%
SVAS BIOSANA SPA / SVS.MI FAQ
What is the ChartMill fundamental rating of SVAS BIOSANA SPA (SVS.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to SVS.MI.
What is the valuation status of SVAS BIOSANA SPA (SVS.MI) stock?
ChartMill assigns a valuation rating of 7 / 10 to SVAS BIOSANA SPA (SVS.MI). This can be considered as Undervalued.
How profitable is SVAS BIOSANA SPA (SVS.MI) stock?
SVAS BIOSANA SPA (SVS.MI) has a profitability rating of 5 / 10.
How financially healthy is SVAS BIOSANA SPA?
The financial health rating of SVAS BIOSANA SPA (SVS.MI) is 4 / 10.
How sustainable is the dividend of SVAS BIOSANA SPA (SVS.MI) stock?
The dividend rating of SVAS BIOSANA SPA (SVS.MI) is 5 / 10 and the dividend payout ratio is 19.64%.